IODOSORB Gel

Cadexomer Gel with lodine

 

Significant evidence at the highest level

Coclusions from the Cochrane Review of antiseptics and antibiotics
for venous leg ulcers

Click here to learn more

Click here to read the Cochrane Review

Reimbursement information

Reimbursement guide

Reimbursement overview

IODOSORB/IODOFLEX Products

IODOSORB / IODOFLEX
Learn more

Overview

Description

IODOSORB Gel is a sterile formulation of Cadexomer Iodine. When applied to the wound, IODOSORB cleans it by absorbing fluids, removing exudate, slough and debris and forming a gel over the wound surface. As the gel absorbs exudate, iodine is released, killing bacteria and changing color as the iodine is used up.


Features

A 3-in-1 mode of action kills bacteria, manages exudate, and debrides the wound bed.


Benefits

  • Helps Promote Wound Healing
    Exudate and debris is removed effectively.
    IODOSORB helps to promote a clean wound healing environment.
    A change in color (white) indicates when IODOSORB should be changed.
    Gel formed over the wound promotes moist healing.
    Accelerated healing rates can lead to earlier patient discharges.
  • Patient comfort
    IODOSORB Gel assists in reducing bacterial load, associated pain is reduced which can improve quality of life.
    IODOSORB is a non-adhesive which can reduce trauma when product is changed encouraging patient compliance.


Indications

IODOSORB Gel - For use in cleaning wet ulcers and wounds such as venous stasis ulcers, pressure sores, diabetic foot ulcers, and infected traumatic and surgical wounds.


Precautions

As IODOSORB Gel contains 0.9% w/w iodine it should not be used in patients with known or suspected Iodine sensitivity. IODOSORB Gel is contraindicated in Hashimoto's Thyroiditis. In patients with a prior history of Graves Disease it is not recommended to use iodine containing products, which includes IODOSORB Gel. The gel should not be used in the case of non-toxic nodular goitre. Patients with a past history of any thyroid disorder are more susceptible to alteration in thyroid metabolism with chronic IODOSORB therapy. Iodine is absorbed systemically especially when large wounds are treated. In endemic goitre there has been isolated reports of hyperthyroidism associated with IODOSORB. There is a potential for interaction of iodine with the following drugs and therefore co-administration is not recommended, Lithium, Sulphafurazoles and Sulphonylureas. It has been observed occasionally that an adherent crust can form when the dressing is not changed with significant frequency. Iodine can cross the placental barrier and is secreted into milk. Do not use IODOSORB in pregnant or lactating women.


Ordering Codes

Catalog# Size Units
6602124014 10g 4 tubes
6602125040 40g 1 tube

Instructions for Use

Step 1

Open tube and squeeze gel on to a non-adherent gauze to the shape of the ulcer and to a depth of 3 to 4 mm. Position the gel face of the gauze on the wound surface and apply mild pressure to fix in place.


Step 2

Gently take off the existing dressing which should be moistened with saline if it is tending to adhere to the wound surface. Remove any remaining IODOSORB with a gentle stream of saline or sterile water if applicable. Gently blot away any excess fluid before re-applying IODOSORB.

Please see Overview Tab for Precautions